Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Human Des [1-3] IGF-I

Human Des[1-3]insulin-like Growth Factor-I (IGF-I) is a 67 amino acid analogue of human IGF-I lacking the N-terminal tripeptide Gly-Pro-Glu. Human Des[1-3]IGF-I is more potent than IGF-I in vitro and in vivo. This increased potency is due to reduced binding of human Des[1-3]IGF-I to most of the IGF binding proteins which modify the biological actions of IGF-I. Human Des[1-3]IGF-I binds to the type 1 IGF receptor with similar affinity to wild type IGF-I. This is a high quality research reagent for use in studies on cell growth, IGF receptors and IGF binding proteins.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Human Des[1-3]insulin-like Growth Factor-I (IGF-I) is a 67 amino acid analogue of human IGF-I lacking the N-terminal tripeptide Gly-Pro-Glu. Human Des[1-3]IGF-I is more potent than IGF-I in vitro and in vivo. This increased potency is due to reduced binding of human Des[1-3]IGF-I to most of the IGF binding proteins which modify the biological actions of IGF-I. Human Des[1-3]IGF-I binds to the type 1 IGF receptor with similar affinity to wild type IGF-I. This is a high quality research reagent for use in studies on cell growth, IGF receptors and IGF binding proteins.

Connected topics

Follow this recovery question